Tema ETFs’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-138,276
Closed -$731K 585
2026
Q1
$731K Buy
138,276
+38,100
+38% +$220K 0.05% 290
2025
Q4
$538K Buy
+100,176
New +$463K 0.04% 347

Other funds holding CMPX

Tema ETFs's CMPX Position: Q2 2026 in Review

Tema ETFs sold out of Compass Therapeutics (CMPX) in Q2 2026, closing a stake of 138,276 shares — an estimated $731K sold.

Tema ETFs first reported a position in CMPX in Q4 2025 and held it in 2 quarters. The position peaked at $731K in Q1 2026. 9 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Tema ETFs reported no remaining Compass Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Tema ETFs sold 138,276 Compass Therapeutics shares in Q2 2026, an estimated $731K.
  • Tema ETFs first reported a position in Compass Therapeutics in Q4 2025 and held it in 2 quarters.
  • Tema ETFs's Compass Therapeutics position peaked at $731K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.